Investor Shelf

Funder directory / Netherlands / Venture capital firms

BioGeneration Ventures

Venture capitalNaarden, Netherlandsbiogenerationventures.comVerified 9 Nov 2026

BioGeneration Ventures is a venture capital firm focused on seed and early-stage investments in European life sciences and biotech companies. It generally acts as a lead investor to build and accelerate product development for high unmet medical needs.

StagesSeed · Series A
Invests inEurope
Deals recorded40

What they invest in

  • We are a venture capital firm specialised in seed investment for innovative early stage companies. source
  • BGV generally acts as lead investor. source

All investments and operations

40 operations
CompanyRoundAmountDateCo-investorsSource
Acerta Pharma––––Portfolio page
arGEN-X––––Portfolio page
Artica Therapeutics––––Portfolio page
Avidicure––––Portfolio page
Azafaros––––Portfolio page
BioCeros––––Portfolio page
Brandaris Therapeutics––––Portfolio page
Brenig––––Portfolio page
Catalym––––Portfolio page
Citryll––––Portfolio page
Show all 40 operations
Complement Therapeutics––––Portfolio page
Confo Therapeutics––––Portfolio page
Dezima Pharma––––Portfolio page
Dunad––––Portfolio page
Epsilogen––––Portfolio page
Fibrocor––––Portfolio page
FundaMental Pharma––––Portfolio page
Genase Therapeutics––––Portfolio page
Kivu Bioscience––––Portfolio page
Lanthio––––Portfolio page
Mellon Medical––––Portfolio page
Mironid––––Portfolio page
NewAmsterdam Pharma––––Portfolio page
NorthSea Therapeutics––––Portfolio page
NovioGendix––––Portfolio page
Phlox––––Portfolio page
Phosphoenix––––Portfolio page
Progentix Orthobiology––––Portfolio page
River BioMedics––––Portfolio page
RougeTx––––Portfolio page
Scenic Biotech––––Portfolio page
STANT––––Portfolio page
Staten Biotechnology––––Portfolio page
Tanai Therapeutics––––Portfolio page
TargED Biopharmaceuticals––––Portfolio page
Tessellate Bio––––Portfolio page
Tiga Tx––––Portfolio page
VarmX––––Portfolio page
VectorY––––Portfolio page
XS Innovations––––Portfolio page

Exits

  • Acerta Pharma Acquired by AstraZeneca2016 · Source

Shown only when an exit is documented by a public source.

Similar funders